What was the market valuation of the US oral cancer-diagnostics market in 2024?

The market valuation was $674.57 Million in 2024. Read More

What is the projected market valuation for the US oral cancer-diagnostics market in 2035?

The projected valuation for 2035 is $1,120.0 Million. Read More

What is the expected CAGR for the US oral cancer-diagnostics market during the forecast period 2025 - 2035?

The expected CAGR during this period is 4.72%. Read More

Which diagnostic type had the highest valuation in the US oral cancer-diagnostics market in 2024?

Biopsy had the highest valuation at $134.91 Million in 2024. Read More

What is the projected valuation for oral squamous cell carcinoma diagnostics by 2035?

The projected valuation for oral squamous cell carcinoma diagnostics is between $300.0 Million and $500.0 Million by 2035. Read More

Which end-user segment accounted for the largest share in the US oral cancer-diagnostics market in 2024?

Hospitals and clinics accounted for the largest share, with a valuation of $439.57 Million in 2024. Read More

What is the projected growth for the biopsy segment in the US oral cancer-diagnostics market by 2035?

The biopsy segment is projected to grow to between $215.0 Million and $300.0 Million by 2035. Read More

Which key player is based in the US and is involved in the oral cancer-diagnostics market?

Thermo Fisher Scientific is a key player based in the US involved in this market. Read More

What is the valuation range for the end-user segment 'Research and Academic Institutes' in 2035?

The valuation range for 'Research and Academic Institutes' is projected to be between $134.91 Million and $224.0 Million by 2035. Read More

How does the valuation of oral cavity lymphomas diagnostics compare to other indications in 2024?

Oral cavity lymphomas diagnostics had a valuation of $40.0 Million in 2024, which is lower compared to other indications. Read More

US Oral Cancer Diagnostics Market

ID: MRFR/MED/11317-HCR

100 Pages

Rahul Gotadki

Last Updated: April 06, 2026

US Oral Cancer Diagnostics Market Research Report By Indication (Oral Squamous Cell Carcinoma, Oral Verrucous Carcinoma, Mucoepidermoid Carcinoma, Oral Cavity Lymphomas), By Diagnosis Type (Endoscopy, Biopsy, X-Ray, Computed Tomography (CT), Positron Emission Tomography (PET), Magnetic Resonance Imaging (MRI), Ultrasonography, Fluorescence Imaging) and By End User (Hospitals and Clinics, Research and Academic Institutes) - Growth & Industry Forecast 2025 To 2035

US Oral Cancer Diagnostics Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Security, Access Control and Robotics, BY Diagnosis Type (USD Million)
  1. 4.1.1 Biopsy
  2. 4.1.2 Endoscopy
  3. 4.1.3 Computed Tomography (C.T.)
  4. 4.1.4 X-ray
  5. 4.1.5 Ultrasonography
  6. 4.1.6 Magnetic Resonance Imaging (MRI)
  7. 4.1.7 Fluorescence Imaging
  8. 4.1.8 Positron Emission Tomography (PET)
  9. 4.1.9 Others
2. 4.2 Security, Access Control and Robotics, BY Indication (USD Million)
  1. 4.2.1 Oral Verrucous Carcinoma
  2. 4.2.2 Oral Squamous Cell Carcinoma
  3. 4.2.3 Mucoepidermoid Carcinoma (Salivary Gland)
  4. 4.2.4 Oral Cavity Lymphomas
  5. 4.2.5 Others
3. 4.3 Security, Access Control and Robotics, BY End-User (USD Million)
  1. 4.3.1 Research and Academic Institutes
  2. 4.3.2 Hospitals and Clinics
  3. 4.3.3 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Security, Access Control and Robotics
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Security, Access Control and Robotics
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Thermo Fisher Scientific (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Roche (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Abbott Laboratories (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Becton Dickinson (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Hologic (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Qiagen (DE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Agilent Technologies (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Illumina (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY DIAGNOSIS TYPE
3. 6.3 US MARKET ANALYSIS BY INDICATION
4. 6.4 US MARKET ANALYSIS BY END-USER
5. 6.5 KEY BUYING CRITERIA OF SECURITY, ACCESS CONTROL AND ROBOTICS
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF SECURITY, ACCESS CONTROL AND ROBOTICS
8. 6.8 DRIVERS IMPACT ANALYSIS: SECURITY, ACCESS CONTROL AND ROBOTICS
9. 6.9 RESTRAINTS IMPACT ANALYSIS: SECURITY, ACCESS CONTROL AND ROBOTICS
10. 6.10 SUPPLY / VALUE CHAIN: SECURITY, ACCESS CONTROL AND ROBOTICS
11. 6.11 SECURITY, ACCESS CONTROL AND ROBOTICS, BY DIAGNOSIS TYPE, 2024 (% SHARE)
12. 6.12 SECURITY, ACCESS CONTROL AND ROBOTICS, BY DIAGNOSIS TYPE, 2024 TO 2035 (USD Million)
13. 6.13 SECURITY, ACCESS CONTROL AND ROBOTICS, BY INDICATION, 2024 (% SHARE)
14. 6.14 SECURITY, ACCESS CONTROL AND ROBOTICS, BY INDICATION, 2024 TO 2035 (USD Million)
15. 6.15 SECURITY, ACCESS CONTROL AND ROBOTICS, BY END-USER, 2024 (% SHARE)
16. 6.16 SECURITY, ACCESS CONTROL AND ROBOTICS, BY END-USER, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY DIAGNOSIS TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY INDICATION, 2025-2035 (USD Million)
  3. 7.2.3 BY END-USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Security, Access Control and Robotics Market Segmentation

Security, Access Control and Robotics By Diagnosis Type (USD Million, 2025-2035)

Biopsy
Endoscopy
Computed Tomography (C.T.)
X-ray
Ultrasonography
Magnetic Resonance Imaging (MRI)
Fluorescence Imaging
Positron Emission Tomography (PET)
Others

Security, Access Control and Robotics By Indication (USD Million, 2025-2035)

Oral Verrucous Carcinoma
Oral Squamous Cell Carcinoma
Mucoepidermoid Carcinoma (Salivary Gland)
Oral Cavity Lymphomas
Others

Security, Access Control and Robotics By End-User (USD Million, 2025-2035)

Research and Academic Institutes
Hospitals and Clinics
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”